Chronic Ailments Fuel Indian Pharma Growth in November 2024

The Indian pharmaceutical market showed significant recovery, demonstrating solid growth in major therapeutic fields such as dermatology, respiratory therapies, cardiac treatment, and pain relief in November. As per IQVIA's most recent Market...

Diagnostics Market Expands as AI Revolutionizes Healthcare Solutions

The increasing use of AI technologies in the healthcare sector aids in diagnostics market growth. Additionally, the demand for quicker diagnosis procedures can positively influence the market. AI promotes advancements in radiology, pathology...

Respiratory Drug Demand Soars Amid Rising Cases of Asthma and COPD

Increased demand for asthma, chronic obstructive pulmonary disease (COPD), and cough and cold subgroups driven the demand for respiratory drugs and also a surge in OPD admissions too, according to medical experts and industry insiders. Sales of...

Conduit Pharma Partners with Sarborg to Drive AI Innovation in Pharma

Conduit Pharmaceutical's collaboration with Sarborg strengthens their dedication to using AI-based solutions to promote growth, provide value to shareholders, and sustain a competitive advantage in the pharmaceutical industry. Conduit is dedicated...

Heparin Market Expands with Rising R&D and Therapeutic Innovations

The global heparin market is fueled by the rising incidence of coagulation disorders, alongside a growing focus on Research and Development efforts and novel therapeutic uses of heparin. The market is projected to expand by USD 3.34 billion from...

Pharma Giants Eye US Market Growth with Complex Generics by 2025

Indian pharmaceutical firms, having gained from favorable sector trends like steady generic pricing and opportunities arising from shortages, alongside stable raw material costs over the last 18-24 months, are expected to advance further in...

Afrezza Revolutionizes Diabetes Care with Inhalable Insulin

Afrezza is the first and sole noninjection insulin created for individuals with both type 1 and type 2 diabetes mellitus. Afrezza, created and produced by MannKind Corporation (MannKind) in the USA, is intended to enhance glycemic control in adult...

Counterfeit Drug Detection Market to Grow 3.3% CAGR

The expansion of the global counterfeit drug detection device market is propelled by a compounded annual growth rate (CAGR) of 3.3% in the upcoming ten years, indicating an increased international emphasis on addressing the rising issue of fake...

Pharma FDI Surges After 48% Dip Last Year

The Foreign Direct Investment (FDI) equity into the pharmaceutical industry has shown significant growth in the first half of 2024-25, following a 48 percent drop in fiscal 2023-24 compared to the prior year. The quarter from April to September of...

Pharma Packaging Market Grows with Innovation and Sustainability Focus

The global pharmaceutical packaging market is consistently expanding due to the demand for more innovative packaging that improves drug effectiveness while integrating sustainable packaging solutions. The Global Pharmaceutical Packaging Market is...